Works matching IS 10073639 AND DT 2024 AND VI 34 AND IP 2

Results: 10

乳腺导管原位癌的影像学表现与分子分型、组织病理学分级及预后相关性的研究进展.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 201, doi. 10.19401/j.cnki.1007-3639.2024.02.008

By:

刘琪;
常才;
李佳伟

Publication type:

Article

2023年中国乳腺癌重要临床研究成果及最新进展.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 135, doi. 10.19401/j.cnki.1007-3639.2024.02.001

By:

张琪;
修秉虬;
吴炅

Publication type:

Article

KDM4A通过下调BMP9促进乳腺癌细胞MDAMB-231的迁移和侵袭.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 176, doi. 10.19401/j.cnki.1007-3639.2024.02.00

By:

陈远香;
余涛;
杨诗雨;
曾涛;
魏兰;
张彦

Publication type:

Article

局部进展期直肠癌新辅助放化疗后肿瘤退缩的影响因素分析及预测模型构建.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 191, doi. 10.19401/j.cnki.1007-3639.2024.02.007

By:

刘志昱;
徐栋;
陈西昊;
李纪鹏

Publication type:

Article

2023年改变早期乳腺癌临床实践的重要研究成果及进展.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 151, doi. 10.19401/j.cnki.1007-3639.2024.02.003

By:

王昭卜;
黎星;
于鑫淼;
金锋

Publication type:

Article

2023年改变晚期乳腺癌临床实践的重要研究成果及进展.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 143, doi. 10.19401/j.cnki.1007-3639.2024.02.002

By:

张思源;
江泽飞

Publication type:

Article

BRCA1/2胚系突变对三阴性乳腺癌患者放疗后第二原发肿瘤的影响.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 185, doi. 10.19401/j.cnki.1007-3639.2024.02.006

By:

胡晓钰;
蔡毓文;
叶富贵;
邵志敏;
胡伟刚;
余科达

Publication type:

Article

基于中国人群的BRCA胚系突变筛查专家共识(2024年版).

Published in:: China Oncology, 2024, v. 34, n. 2, p. 220, doi. 10.19401/j.cnki.1007-3639.2024.02.010
Publication type:: Article

AK-HER2与参照药治疗HER2阳性转移性乳腺癌患者的疗效、体内代谢特征、安全性和免疫原性比较:-项多中心、随机、双盲Ⅲ期等效性临床试验.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 161, doi. 10.19401/j.cnki.1007-3639.2024.02.004

By:

罗扬;
孙涛;
邵志敏;
崔久嵬;
潘跃银;
张清媛;
程颖;
李惠平;
杨燕;
叶长生;
于国华;
王京芬;
刘运江;
刘新兰;
周宇红;
柏玉举;
谷元廷;
王晓稼;
徐兵河;
宋礼华

Publication type:

Article

人工智能在类器官研究中的应用进展与挑战.

Published in:

China Oncology, 2024, v. 34, n. 2, p. 210, doi. 10.19401/j.cnki.1007-3639.2024.02.009

By:

吴洪基;
王海霞;
汪玲;
罗小刚;
邹冬玲

Publication type:

Article